Literature DB >> 28379415

Adaptation to European Spanish and psychometric properties of the Patient Activation Measure 13 in patients with chronic diseases.

Cibeles Moreno-Chico1,2, Luis González-de Paz3,4, Cristina Monforte-Royo1, Emilia Arrighi5, M Dolores Navarro-Rubio3,5, Alberto Gallart Fernández-Puebla1.   

Abstract

Background: The 13-item Patient Activation Measure (PAM-13) is an instrument that assesses people's knowledge, skills and confidence for self-management of their health and health care. Scores on the PAM-13 have been shown to predict adherence to health behaviours, health-related outcomes and health care costs.
Objectives: To develop a European Spanish adaptation of the original PAM-13 and to examine its psychometric properties in a sample of chronic patients.
Methods: The PAM-13 was forward-backward translated and then completed by chronic patients attending a primary health care centre. Data were analysed with a Rasch model. We assessed the functioning of the rating scale, its reliability, the item goodness-of-fit, differential item functioning (DIF), local dependence, unidimensionality and correlation analysis.
Results: A total of 208 patients (80%) completed the questionnaire. Data showed a fit to the Rasch model. More than 50% of patients endorsed all the items. Item rank for the Spanish sample was similar to the original, with few differences. We found significant differences (P < 0.05) in PAM-13 measures according to adherence to prescribed medicines and positive correlations with self-efficacy and physical quality of life. Conclusions: The European Spanish PAM-13 is a reliable and valid instrument for assessing activation in patients with chronic disease in Spain. We suggest adding new items to the instrument so as to examine patients with higher activation levels in the future. Further studies are needed to evaluate the usefulness of this new Spanish PAM-13 in different settings and populations, as well as to examine the relationship between PAM-13 scores and other health-related outcomes.
© The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Chronic disease; Spain; patient activation; primary health care; psychometrics; translation

Mesh:

Year:  2017        PMID: 28379415     DOI: 10.1093/fampra/cmx022

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  4 in total

1.  Measuring patient activation in Chinese patients with hypertension and/or diabetes: reliability and validity of the PAM13.

Authors:  Huijuan Zeng; Runsheng Jiang; Mei Zhou; Linxiong Wu; Bo Tian; Yao Zhang; Fanwei Qu
Journal:  J Int Med Res       Date:  2019-10-10       Impact factor: 1.671

2.  Effectiveness of a web-based decision aid for patients with generalised anxiety disorder: a protocol for a randomised controlled trial.

Authors:  Lilisbeth Perestelo-Pérez; Amado Rivero-Santana; Vanesa Ramos-García; Yolanda Álvarez-Pérez; Andrea Duarte-Díaz; Alezandra Torres-Castaño; Maria Del Mar Trujillo-Martín; Tasmania Del Pino-Sedeño; Ana Isabel González-González; Pedro Serrano-Aguilar
Journal:  BMJ Open       Date:  2020-12-10       Impact factor: 2.692

3.  A motivational interview program for cardiac rehabilitation after acute myocardial infarction: study protocol of a randomized controlled trial in primary healthcare.

Authors:  Rocío Rodríguez-Romero; Carles Falces; Belchin Kostov; Noemí García-Planas; Esther Blat-Guimerà; María C Alvira-Balada; Mireia López-Poyato; María L Benito-Serrano; Ingrid Vidiella-Piñol; Juan J Zamora-Sánchez; Marta Benet; Manuel V Garnacho-Castaño; Susana Santos-Ruiz; Rosalia Santesmases-Masana; Silvia Roura-Rovira; Jaume Benavent-Areu; Antoni Sisó-Almirall; Luis González-de Paz
Journal:  BMC Prim Care       Date:  2022-05-06

4.  Effectiveness and cost-effectiveness of a virtual community of practice to improve the empowerment of patients with ischaemic heart disease: study protocol of a randomised controlled trial.

Authors:  Ana Isabel González-González; Lilisbeth Perestelo-Pérez; Débora Koatz; Marta Ballester; Valeria Pacheco-Huergo; Vanesa Ramos-García; Alezandra Torres-Castaño; Amado Rivero-Santana; Ana Toledo-Chávarri; Cristina Valcárcel-Nazco; Juana Mateos-Rodilla; Juan Carlos Obaya-Rebollar; Javier García-García; Santiago Díaz-Sánchez; Luis Morales-Cobos; Josep María Bosch-Fontcuberta; Nuria Vallejo-Camazón; Ana Rodríguez-Almodovar; José Carlos Del Castillo; Marcos Muñoz-Balsa; Yolanda Del Rey-Granado; Sofía Garrido-Elustondo; María-Eugenia Tello-Bernabé; Ana Belén Ramírez-Puerta; Carola Orrego
Journal:  BMJ Open       Date:  2020-10-12       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.